4/A: West Pharmaceutical Services Director Janet Haugen Acquires Shares

Director Janet Haugen acquired 247 shares of West Pharmaceutical Services common stock on December 16, 2024, as part of a restricted stock unit award.

Summary

• Janet Haugen, a director at West Pharmaceutical Services, acquired 247 shares of common stock on December 16, 2024.
• These shares were awarded as restricted stock units and will vest fully on the date of the next annual shareholder meeting.
• The shares are part of the Deferred Compensation Plan for Outside Directors.
• This transaction was reported in an amended Form 4 filing on January 17, 2025, which corrected the original filing from December 18, 2024.
• A power of attorney document was also filed, authorizing Luis Cantarero, Louis Lalli, Ryan Metz, and Caitlin Hippeli to act on behalf of Janet Haugen for Section 16(a) filings.

Sentiment

Score: 7

Explanation: The document reflects a routine insider transaction, which is generally neutral to positive. The acquisition of shares by a director can be seen as a positive sign of confidence in the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The restricted stock units will vest on the date of the next annual shareholder meeting.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies. It reflects standard practice for director compensation and reporting requirements.

Comparison to Industry Standards

• The reporting of insider transactions via Form 4 filings is a standard practice for all publicly traded companies in the United States.
• The use of restricted stock units as part of director compensation is also a common practice among companies of similar size and industry to West Pharmaceutical Services.
• The vesting schedule of the restricted stock units, tied to the next annual shareholder meeting, is a typical approach to align director interests with shareholder interests.

Stakeholder Impact

• The share acquisition by a director may have a slightly positive impact on shareholder sentiment.

Next Steps

• The restricted stock units will vest on the date of the next annual shareholder meeting.

Key Dates

Keywords

Form 4, Section 16, Beneficial Ownership, Restricted Stock Units, Director, West Pharmaceutical Services, Share Acquisition, Power of Attorney